Search Results

Filter
  • 1-10 of  199,023 results for ""PARKINSONIAN disorders""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Management of lower urinary tract symptoms in Parkinsonian disorders.

  • Authors : Guillot-Tantay C; Service d'urologie, Hôpital Foch, 40, rue Worth, 92150 Suresnes, France. Electronic address: .

Subjects: Lower Urinary Tract Symptoms*/Lower Urinary Tract Symptoms*/Lower Urinary Tract Symptoms*/diagnosis ; Lower Urinary Tract Symptoms*/Lower Urinary Tract Symptoms*/Lower Urinary Tract Symptoms*/etiology ; Lower Urinary Tract Symptoms*/Lower Urinary Tract Symptoms*/Lower Urinary Tract Symptoms*/therapy

  • Source: Revue neurologique [Rev Neurol (Paris)] 2024 Jan-Feb; Vol. 180 (1-2), pp. 101-106. Date of Electronic Publication: 2023 Dec 12.Publisher: Masson Country of Publication: France NLM ID: 2984779R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0035-3787

Record details

×
Academic Journal

PET imaging of synaptic density in Parkinsonian disorders.

  • Authors : Martin SL; Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Uribe C

Subjects: Parkinsonian Disorders*/Parkinsonian Disorders*/Parkinsonian Disorders*/diagnostic imaging ; Parkinsonian Disorders*/Parkinsonian Disorders*/Parkinsonian Disorders*/metabolism ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism

  • Source: Journal of neuroscience research [J Neurosci Res] 2024 Mar; Vol. 102 (3), pp. e25253. Date of Electronic Publication: 2023 Oct 10.Publisher: Wiley Interscience Country of Publication: United States NLM ID: 7600111 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders.

  • Authors : Fernandes Gomes B; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden. Electronic address: .; Farris CM

Subjects: Synucleinopathies* ; Parkinsonian Disorders*/Parkinsonian Disorders*/Parkinsonian Disorders*/diagnosis ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/diagnosis

  • Source: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2023 Dec; Vol. 117, pp. 105807. Date of Electronic Publication: 2023 Aug 14.Publisher: Elsevier Science Country of Publication: England NLM ID: 9513583 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Corneal confocal microscopy demonstrates varying degrees of neurodegeneration in atypical parkinsonian disorders.

  • Authors : Lim SH; Department of Neurology, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.; Ferdousi M

Subjects: Parkinsonian Disorders*/Parkinsonian Disorders*/Parkinsonian Disorders*/diagnostic imaging ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/complications ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/diagnostic imaging

  • Source: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2023 Dec; Vol. 117, pp. 105899. Date of Electronic Publication: 2023 Nov 04.Publisher: Elsevier Science Country of Publication: England NLM ID: 9513583 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease.

  • Authors : Pereira JB; Division of Neuro, Department of Clinical Neutaroscience, Karolinska Institutet, Solna, Sweden.; Clinical Memory Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

Subjects: Lewy Body Disease*/Lewy Body Disease*/Lewy Body Disease*/diagnosis ; Parkinsonian Disorders*/Parkinsonian Disorders*/Parkinsonian Disorders*/diagnosis ; Neurodegenerative Diseases*

  • Source: Nature aging [Nat Aging] 2023 Oct; Vol. 3 (10), pp. 1201-1209. Date of Electronic Publication: 2023 Sep 18.Publisher: Nature Publishing Group US Country of Publication: United States NLM ID: 101773306 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.

  • Authors : Taha HB; Department of Integrative Biology & Physiology, University of California Los Angeles, Los Angeles, California, USA.; Ati SS

Subjects: Extracellular Vesicles* ; Multiple System Atrophy*/Multiple System Atrophy*/Multiple System Atrophy*/diagnosis ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/diagnosis

  • Source: CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Dec; Vol. 29 (12), pp. 3741-3755. Date of Electronic Publication: 2023 Jul 07.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101473265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/complications ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/epidemiology

  • Source: PloS one [PLoS One] 2023 Jul 31; Vol. 18 (7), pp. e0285349. Date of Electronic Publication: 2023 Jul 31 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Botulinum toxin in the management of parkinsonian disorders.

  • Authors : Grippe T; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada

Subjects: Botulinum Toxins*/Botulinum Toxins*/Botulinum Toxins*/therapeutic use ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Gait Disorders, Neurologic*/Gait Disorders, Neurologic*/Gait Disorders, Neurologic*/drug therapy

  • Source: Toxicon : official journal of the International Society on Toxinology [Toxicon] 2023 Aug 15; Vol. 232, pp. 107209. Date of Electronic Publication: 2023 Jul 08.Publisher: Pergamon Press Country of Publication: England NLM ID: 1307333 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  199,023 results for ""PARKINSONIAN disorders""